Yuanrong Dai

1.0k total citations
43 papers, 719 citations indexed

About

Yuanrong Dai is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuanrong Dai has authored 43 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuanrong Dai's work include Immune Response and Inflammation (8 papers), Asthma and respiratory diseases (8 papers) and Antimicrobial Peptides and Activities (4 papers). Yuanrong Dai is often cited by papers focused on Immune Response and Inflammation (8 papers), Asthma and respiratory diseases (8 papers) and Antimicrobial Peptides and Activities (4 papers). Yuanrong Dai collaborates with scholars based in China, United States and Poland. Yuanrong Dai's co-authors include Han Gao, Guang Liang, Yali Zhang, Guang Liang, Tingting Xu, Lili Dong, Xiaoou Shan, Fengli Xu, Yali Zhang and Liqin Wu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yuanrong Dai

40 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanrong Dai China 15 256 245 141 132 80 43 719
Xiaoou Shan China 17 304 1.2× 215 0.9× 57 0.4× 56 0.4× 54 0.7× 61 874
Longwang Chen China 16 247 1.0× 147 0.6× 60 0.4× 37 0.3× 32 0.4× 35 603
Weiji Lin China 15 217 0.8× 149 0.6× 86 0.6× 80 0.6× 20 0.3× 29 744
Chiara Leuratti Switzerland 16 279 1.1× 71 0.3× 66 0.5× 51 0.4× 127 1.6× 35 906
Jui‐Chieh Chen Taiwan 16 298 1.2× 73 0.3× 84 0.6× 49 0.4× 43 0.5× 35 731
Yasushi Ohno Japan 19 326 1.3× 50 0.2× 94 0.7× 259 2.0× 37 0.5× 61 1.0k
David Cheng United States 18 466 1.8× 84 0.3× 47 0.3× 44 0.3× 93 1.2× 22 778
Guy Faust United Kingdom 8 341 1.3× 91 0.4× 194 1.4× 47 0.4× 47 0.6× 30 1.0k
Fengli Xu China 12 218 0.9× 123 0.5× 34 0.2× 29 0.2× 74 0.9× 14 464
Edwina N. Scott United Kingdom 10 430 1.7× 51 0.2× 128 0.9× 60 0.5× 107 1.3× 12 956

Countries citing papers authored by Yuanrong Dai

Since Specialization
Citations

This map shows the geographic impact of Yuanrong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanrong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanrong Dai more than expected).

Fields of papers citing papers by Yuanrong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanrong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanrong Dai. The network helps show where Yuanrong Dai may publish in the future.

Co-authorship network of co-authors of Yuanrong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanrong Dai. A scholar is included among the top collaborators of Yuanrong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanrong Dai. Yuanrong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Tingting, Meiyan Wang, Yue Tang, et al.. (2024). Chalcone-derivative L6H21 attenuates the OVA-induced asthma by targeting MD2. European journal of medical research. 29(1). 65–65. 2 indexed citations
3.
Yang, Weijie, Yifan Zhang, Ling Wang, et al.. (2024). The admission inflammatory biomarkers profile of elderly hip fractures and its association with one-year walking independence and mortality: a prospective study. International Orthopaedics. 49(1). 19–28. 1 indexed citations
4.
Dai, Yuanrong, et al.. (2024). Role of vascular endothelium and exosomes in cancer progression and therapy (Review). International Journal of Oncology. 66(1). 2 indexed citations
5.
Gu, Xiaofei, et al.. (2021). Roxithromycin attenuates inflammation via modulation of RAGE-influenced calprotectin expression in a neutrophilic asthma model. Annals of Translational Medicine. 9(6). 494–494. 3 indexed citations
6.
Wu, Liqin, et al.. (2021). Azithromycin induces apoptosis in airway smooth muscle cells through mitochondrial pathway in a rat asthma model. Annals of Translational Medicine. 9(14). 1181–1181. 7 indexed citations
7.
Ye, Hua, Chengguang Zhao, Lehe Yang, et al.. (2020). Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China. EClinicalMedicine. 26. 100492–100492. 7 indexed citations
8.
Dai, Wei, Jie Lin, Yaxin Zhao, et al.. (2020). Clinical features of 64 patients (outside Hubei) with COVID-19 in Wenzhou, China. Journal of Thoracic Disease. 12(10). 6127–6131. 1 indexed citations
9.
Xu, Tingting, Chunyan Lu, Wei‐Min Dai, et al.. (2019). Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway. Aging. 11(21). 9310–9327. 36 indexed citations
10.
Lu, Chunyan, Bing Zhang, Tingting Xu, et al.. (2019). Piperlongumine reduces ovalbumin‑induced asthma and airway inflammation by regulating nuclear factor‑κB activation. International Journal of Molecular Medicine. 44(5). 1855–1865. 17 indexed citations
11.
Zhang, Yali, Tingting Xu, Chuchu Sun, et al.. (2017). Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury. British Journal of Pharmacology. 175(5). 840–854. 62 indexed citations
12.
Gao, Han, et al.. (2017). Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target. Journal of Immunology Research. 2017. 1–12. 64 indexed citations
13.
Zhang, Yali, Jianzhang Wu, Shilong Ying, et al.. (2016). Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Scientific Reports. 6(1). 25130–25130. 51 indexed citations
14.
Zhang, Yali, Zhiguo Feng, Tingting Xu, et al.. (2016). A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo. Drug Design Development and Therapy. Volume 10. 1947–1959. 12 indexed citations
15.
Wang, Yi, Xiaoou Shan, Yuanrong Dai, et al.. (2015). Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2. Journal of Pharmacology and Experimental Therapeutics. 353(3). 539–550. 68 indexed citations
16.
Xu, Fengli, Yali Zhang, Zhiguo Liu, et al.. (2015). Design, synthesis and biological evaluation of paralleled Aza resveratrol–chalcone compounds as potential anti-inflammatory agents for the treatment of acute lung injury. Bioorganic & Medicinal Chemistry Letters. 25(15). 2998–3004. 30 indexed citations
17.
Zhang, Yali, Dandan Liang, Lili Dong, et al.. (2015). Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Respiratory Research. 16(1). 43–43. 83 indexed citations
18.
Chen, Shujing, et al.. (2014). Cellular stress response and pulmonary inflammation. Microbes and Infection. 16(10). 871–876. 3 indexed citations
19.
Dai, Yuanrong, et al.. (2014). Lung squamous carcinoma with two paraneoplastic syndromes: dermatomyositis and Lambert–Eaton myasthenic syndrome. The Clinical Respiratory Journal. 10(4). 495–499. 10 indexed citations
20.
Xia, Xiaodong, et al.. (2011). Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats. Molecular and Cellular Biochemistry. 359(1-2). 293–299. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026